Revealing spatiotemporal variations in areas potentially linked to COVID-19 spread using fine-grained population data.

Publication date: Jul 02, 2025

The COVID-19 pandemic has highlighted the need to better understand the dynamics of disease spread in cities in order to develop efficient and effective epidemiological strategies. In this study, we utilise fine-grained spatiotemporal population data obtained from mobile devices to identify areas and time of day that may contribute to COVID-19 spread, and investigate how they change throughout different waves of the pandemic. To evaluate the potential risk to city residents, we analyse the correlation between the effective reproduction number and population dynamics at locations regularly visited by these residents. Our case study of Tokyo identifies highly-correlated areas at a fine-grained level, revealing shifts in these areas within cities and across urban and suburban regions as the pandemic progresses. We also explore the characteristics of the potential areas of concern through the lenses of points of interest and population dynamics. Our findings have implications for comprehensively understanding the spatiotemporal dynamics of COVID-19 and offer insights into public health interventions for managing pandemics.

Open Access PDF

Concepts Keywords
Covid Cities
Epidemiological COVID-19
Regularly Humans
Suburban Pandemics
Tokyo Population Dynamics
SARS-CoV-2
Spatio-Temporal Analysis
Tokyo

Semantics

Type Source Name
disease MESH COVID-19
drug DRUGBANK Tropicamide
pathway REACTOME Reproduction
disease MESH infection
drug DRUGBANK Coenzyme M
disease IDO cell
disease MESH privacy
disease IDO process
disease MESH uncertainty
disease MESH emergency
drug DRUGBANK Spinosad
disease MESH community transmission
drug DRUGBANK Methionine
drug DRUGBANK Etoperidone
disease IDO facility
disease MESH community acquired infections
drug DRUGBANK Aspartame
disease IDO contact tracing
disease MESH Influenza
disease IDO site
disease MESH Coronavirus Infections
drug DRUGBANK Haloperidol
disease MESH severe acute respiratory syndrome

Original Article

(Visited 3 times, 1 visits today)